Research grade recombinant protein expands toolkit of available CRISPR nucleases and increases efficiency of homology-directed repair (HDR) to enable more precise genome modifications

SunHydrogen has successfully demonstrated live operation of its commercial-size 1.92m² hydrogen module, producing renewable hydrogen using only sunlight and water. This major milestone showcases the scalability and off-grid potential of the company’s renewable hydrogen production technology.

New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies

IDT launches all-inclusive gene fragments from 7 cents per base with 25% lower turnaround times and next-day shipping powered by its cutting-edge synthetic biology facility

Expanded portfolio offerings include first-to-market product launches to support global health challenges New infectious disease research solutions to be spotlighted at ASM Microbe 2025

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.

A solar-powered nitrate treatment unit is installed to demonstrate circular resource recovery